Goldman Sachs’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Sell
289,025
-302,686
-51% -$12.6M ﹤0.01% 2983
2025
Q4
$27.5M Buy
591,711
+279,998
+90% +$13.5M ﹤0.01% 2068
2025
Q3
$15.3M Buy
311,713
+120,304
+63% +$6.29M ﹤0.01% 2531
2025
Q2
$9.91M Buy
+191,409
New +$7.74M ﹤0.01% 2763

Other funds holding HNGE

Goldman Sachs's HNGE Position: Q1 2026 in Review

Goldman Sachs reduced its Hinge Health (HNGE) stake by 51% in Q1 2026, selling an estimated $12.6M and leaving 289,025 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2983.

Goldman Sachs first reported a position in HNGE in Q2 2025 and has held it in 4 quarters since. The position peaked at $27.5M in Q4 2025. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Goldman Sachs held 289,025 shares of Hinge Health worth $11.1M as of Q1 2026.
  • Goldman Sachs sold 302,686 Hinge Health shares in Q1 2026, an estimated $12.6M.
  • Hinge Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2983 holding.
  • Goldman Sachs first reported a position in Hinge Health in Q2 2025 and has held it in 4 quarters since.
  • Goldman Sachs's Hinge Health position peaked at $27.5M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.